Benign ยท Adnexal mimicICD-10 L72.8

Sebaceous hyperplasia

Senile sebaceous hyperplasia; "sebaceous adenoma" (older โ€” incorrect; sebaceous adenoma is a distinct neoplasm)

Sebaceous hyperplasia is one of the most common benign skin lesions in middle-aged and elderly adults โ€” a single, soft, yellowish, often umbilicated papule on the face (forehead, cheek, nose) representing benign hyperplastic enlargement of normal sebaceous glands around a central follicular opening. Its clinical importance in skin oncology is its very common misdiagnosis as basal cell carcinoma: both share a pearly, telangiectatic, central-umbilicated appearance on the face. Dermoscopy is highly diagnostic โ€” yellow lobular structures around a central crater with peripheral "crown" / "wreath" vessels โ€” and reliably distinguishes sebaceous hyperplasia from BCC. Multiple sebaceous adenomas (a distinct entity) on the face should prompt consideration of Muir-Torre syndrome.

CurrentLast reviewed 26 April 2026
Clinical image of Sebaceous hyperplasia
Sebaceous hyperplasia. Image sourced from DermNet New Zealand. Used under CC BY-NC-ND 4.0. No endorsement implied.

Clinical features

  • Single (or several) soft, dome-shaped, yellowish to flesh-coloured papule, usually 2โ€“5 mm, with central umbilication.
  • Surface โ€” smooth, sometimes lobulated; central crater corresponds to the dilated follicular opening.
  • Distribution โ€” face, particularly forehead, cheek, nose; less often chest, back.
  • Median age 40โ€“60 onwards; both sexes; commoner in oily-skinned, immunosuppressed (especially ciclosporin-treated transplant recipients) and elderly patients.
  • Usually asymptomatic.

Dermoscopy โ€” the BCC discriminator

  • Yellow lobular structures โ€” multiple yellow lobules ("cumulus sign" / "yellow cobblestones") radiating around a central pore.
  • Central crater / umbilication โ€” corresponds to the dilated follicular opening.
  • "Crown" / "wreath" vessels โ€” fine telangiectasias arranged at the periphery of the lesion that do not cross the centre.
  • Absent โ€” arborising vessels (BCC), blue-grey ovoid nests / leaf-like structures (BCC), pigment network (melanocytic).
  • The crown-vessel pattern (peripheral, non-crossing) is the single most useful discriminator from BCC, where vessels arborise across the lesion.

Critical differential โ€” basal cell carcinoma

  • BCC โ€” particularly the nodular subtype on the face โ€” is the most clinically important differential.
  • Discriminating features:
    • BCC โ€” pearly white-pink translucent, arborising vessels crossing the lesion, eroded or ulcerated centre, telangiectasias, blue-grey ovoid nests on dermoscopy; slow growth over months to years.
    • Sebaceous hyperplasia โ€” soft, yellow, umbilicated centre, peripheral crown vessels, no ulceration, stable for years.
  • Other differentials โ€” sebaceous adenoma (usually larger; Muir-Torre context), molluscum contagiosum (firmer, smaller, central white plug, multiple), trichoepithelioma (firm, skin-coloured, around nose / nasolabial; multiple in Brooke-Spiegler), fibrous papule of the face (firm, white, near nose).
  • Biopsy any clinically uncertain lesion โ€” the consequences of missing a BCC outweigh the small inconvenience of biopsy.

Muir-Torre context

  • Sebaceous hyperplasia is benign and common โ€” it is not a marker of Muir-Torre syndrome.
  • Sebaceous adenoma (distinct entity โ€” clinically a yellowish papule, histologically a true adenomatous neoplasm) and sebaceoma, particularly multiple, on the trunk, ARE Muir-Torre markers requiring MMR-protein testing and Lynch syndrome screening โ€” see Muir-Torre syndrome.

Management

  • Reassurance โ€” no treatment required for typical asymptomatic lesions.
  • Treatment options for cosmetic concern:
    • Cautery / electrodesiccation.
    • COโ‚‚ laser ablation.
    • Cryotherapy.
    • Trichloroacetic acid spot peel.
    • Topical retinoid (less effective).
    • Oral isotretinoin in heavily affected immunosuppressed patients.
    • Shave / curettage if histology desired (e.g. diagnostic uncertainty).
  • Biopsy and histology if any diagnostic doubt โ€” particularly to exclude BCC.
  • In organ transplant recipients on ciclosporin, lesions may proliferate dramatically; consider conversion to alternative immunosuppression โ€” see OTRs.

References

  1. Walsh N. Cumulus sign โ€” dermoscopic feature of sebaceous hyperplasia. J Am Acad Dermatol; 2014.
  2. Zaballos P et al. Dermoscopy of sebaceous hyperplasia. Arch Dermatol; 2007.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.